SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 25.19 |
Enterprise Value ($M) | -73.13 |
Book Value ($M) | 91.99 |
Book Value / Share | 25.67 |
Price / Book | 0.26 |
NCAV ($M) | 91.99 |
NCAV / Share | 24.29 |
Price / NCAV | 0.27 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.15 |
Return on Assets (ROA) | -1.25 |
Return on Equity (ROE) | -1.80 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 38.95 |
Current Ratio | 38.95 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 96.69 |
Assets | 96.69 |
Liabilities | 4.69 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -19.49 |
Net Income | -17.60 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 99.87 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | S.H.N. Financial Investments Ltd. | 4.99 | 67.34 | |
13G/A | Janus Henderson Group Plc | 5.40 | -46.32 | |
13G/A | Dellora Investments LP | 10.30 | ||
13G | Lind Global Fund II LP | 9.90 | ||
13G/A | CVI Investments, Inc. | 0.00 | -100.00 | |
13G/A | Stonepine Capital Management, LLC | 9.99 | 0.00 | |
13G | Adage Capital Management, L.P. | 9.99 | ||
13G | Price T Rowe Associates Inc /md/ | 19.99 | ||
13G | Venrock Healthcare Capital Partners III, L.P. | 9.99 | ||
13G | Biotechnology Value Fund L P | 9.99 | ||
13G | Vivo Opportunity Fund Holdings, L.P. | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
rrrr UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C., 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C., 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
554 | 3,778 | 14.66 | |
6,425 | 51,122 | 12.57 | |
13,334 | 100,977 | 13.20 | |
(click for more detail) |
Similar Companies | |
---|---|
SYBX – Synlogic, Inc. | TCRT – Alaunos Therapeutics, Inc. |
TELO – Telomir Pharmaceuticals, Inc. | TGTX – TG Therapeutics, Inc. |
THAR – Tharimmune, Inc. |